1.Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.
Yang YANG ; Ke-Yu LU ; Rui CHENG ; Qin ZHOU ; Guang-Dong FANG ; Hong LI ; Jie SHAO ; Huai-Yan WANG ; Zheng-Ying LI ; Song-Lin LIU ; Zhen-Guang LI ; Jin-Lan CAI ; Mei XUE ; Xiao-Qing CHEN ; Zhao-Jun PAN ; Yan GAO ; Li HUANG ; Hai-Ying LI ; Lei SONG ; San-Nan WANG ; Gui-Hua SHU ; Wei WU ; Meng-Zhu YU ; Zhun XU ; Hong-Xin LI ; Yan XU ; Zhi-Dan BAO ; Xin-Ping WU ; Li YE ; Xue-Ping DONG ; Qi-Gai YIN ; Xiao-Ping YIN ; Jin-Jun ZHOU
Chinese Journal of Contemporary Pediatrics 2022;24(3):240-248
OBJECTIVES:
To explore the optimal maintenance dose of caffeine citrate for preterm infants requiring assisted ventilation and caffeine citrate treatment.
METHODS:
A retrospective analysis was performed on the medical data of 566 preterm infants (gestational age ≤34 weeks) who were treated and required assisted ventilation and caffeine citrate treatment in the neonatal intensive care unit of 30 tertiary hospitals in Jiangsu Province of China between January 1 and December 31, 2019. The 405 preterm infants receiving high-dose (10 mg/kg per day) caffeine citrate after a loading dose of 20 mg/kg within 24 hours after birth were enrolled as the high-dose group. The 161 preterm infants receiving low-dose (5 mg/kg per day) caffeine citrate were enrolled as the low-dose group.
RESULTS:
Compared with the low-dose group, the high-dose group had significant reductions in the need for high-concentration oxygen during assisted ventilation (P=0.044), the duration of oxygen inhalation after weaning from noninvasive ventilation (P<0.01), total oxygen inhalation time during hospitalization (P<0.01), the proportion of preterm infants requiring noninvasive ventilation again (P<0.01), the rate of use of pulmonary surfactant and budesonide (P<0.05), and the incidence rates of apnea and bronchopulmonary dysplasia (P<0.01), but the high-dose group had a significantly increased incidence rate of feeding intolerance (P=0.032). There were no significant differences between the two groups in the body weight change, the incidence rates of retinopathy of prematurity, intraventricular hemorrhage or necrotizing enterocolitis, the mortality rate, and the duration of caffeine use (P>0.05).
CONCLUSIONS
This pilot multicenter study shows that the high maintenance dose (10 mg/kg per day) is generally beneficial to preterm infants in China and does not increase the incidence rate of common adverse reactions. For the risk of feeding intolerance, further research is needed to eliminate the interference of confounding factors as far as possible.
Caffeine/therapeutic use*
;
Citrates
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Respiration, Artificial
;
Retrospective Studies
2.Advances in polydopamine-based drug delivery systems for tumor targeting
Yu-pei SU ; Hao PAN ; Dan-dan LIU ; Jia-hui WANG ; Ping-tian DING ; Wei-san PAN
Acta Pharmaceutica Sinica 2022;57(1):25-35
Polydopamine (PDA) is a novel type of polymer synthesized inspired by adhesion proteins in mussels. It has been widely used in tumor-targeting drug delivery systems due to its natural advantages such as good biocompatibility, excellent photothermal conversion performance, adhesion, high chemical reactivity and multiple drug release response mechanisms. This review summarizes the applications of PDA-based tumor-targeting drug delivery in recent years, hoping to provide references for designing a more reasonable and effective PDA-based multifunctional collaborative tumor therapy platform.
3.Characterization and principal component analysis of functionality-related characteristics of hydroxypropyl methylcellulose type 2208
Wen-bin DENG ; Hao PAN ; Yun-jian LI ; Sen QIAO ; Xiao-tong ZHOU ; Wei-san PAN
Acta Pharmaceutica Sinica 2021;56(1):314-318
Under the guidance of Chinese Pharmacopoeia (2020 edition), the functionality-related characteristics of hydroxypropyl methylcellulose (HPMC) type 2208 from imported A manufacturer, domestic S manufacturer, domestic T manufacturer and different batches of the same manufacturer were characterized. The principal component analysis was used to comprehensively evaluate the functionality-related characteristics. The results were as follows: hydroxypropyl methylcellulose had no significant difference in viscosity and molecular weight distribution between different manufacturers, and there were significant differences in the cumulative particle size distribution of the sample reaches 50% (
4.Discussion on
Chang-Zhen GONG ; Fan-Rong LIANG ; Can-Hui LI ; Wei-Xing PAN ; Yong-Ming LI ; San-Hua LENG ; Arthur Yin FAN ; Song-Ping HAN ; Jing LIU ; Shan WANG ; Zeng-Fu PENG ; Ye-Meng CHEN ; Guan-Hu YANG ; Xu-Ming GU ; Hong SU ; Shao-Bai WANG
Chinese Acupuncture & Moxibustion 2021;41(4):359-364
Professor
Acupuncture
;
Acupuncture Therapy
;
Angina, Stable
;
Combined Modality Therapy
;
Humans
;
Moxibustion
5.Formulation optimization of ginkgo flavonoids matrix tablets by orthogonal design.
Ying-Xin GUO ; Fei LI ; Qian-Qian ZHAO ; Lu XU ; Wei-San PAN ; Wei XIAO ; Xing-Gang YANG
China Journal of Chinese Materia Medica 2013;38(11):1725-1730
Sustained-release tablet has become one of the hottest research spots in the area of sustained release preparations with its unique advantages. At present, a series of shortcomings were exited in the ordinary ginkgo preparations, which were used for the treatment of cardiovascular and cerebrovascular diseases. In order to avoid these shortcomings, ginkgo flavonoids matrix tablets were prepared in this paper. Furthermore, the amount and varieties of matrix material, adhesives and fillers were investigated. Meanwhile, the formulation was optimized by using the method of orthogonal design, and Zero-order, First-order, Higuchi, Ritger-peppas equation were used for the model fitting and mechanism discussing of drug release.
Chemistry, Pharmaceutical
;
methods
;
Flavonoids
;
chemistry
;
pharmacology
;
Ginkgo biloba
;
chemistry
;
Kinetics
;
Tablets
;
chemistry
6.Intestinal absorption kinetics of flurbiprofen in rats.
Jun-Jie PENG ; Cong-Cong LIN ; Jiang LI ; Zhi-Hong ZHU ; Xing-Gang YANG ; Wei-San PAN
Acta Pharmaceutica Sinica 2013;48(3):423-427
To study the in situ intestinal absorption kinetics of flrubiprofen in rats, the absorption of flurbiprofen in small intestine (duodenum, jejunum and ileum) and colon of rats was investigated using in situ single-pass perfusion method and the drug content was measured by HPLC. The effects of drug concentration on the intestinal absorption were investigated. The K(a) and P(app) values of flurbiprofen in the small intestine and colon had no significant difference (P > 0.05). Drug concentration (4.0, 10.0 and 16.0 mg x L(-1)) had no significant influence on the K(a) values (P > 0.05). However, when concentration was 4.0 mg x L(-1) and 10.0 mg x L(-1), significant effect on the P(app) values (P < 0.05) was found, but significant effect on the P(app) values was not shown between 10.0 mg x L(-1) and 16.0 mg x L(-1) (P > 0.05). The K(a) and P(app) values of flurbiprofen on the perfusion flow rate had significant difference (P < 0.05). Flurbiprofen could be absorbed at all segments of the intestine in rats and had no special absorption window. The absorption of flurbiprofen complies with the facilitated diffusion in the general intestinal segments, and accompany with the cytopsistransport mechanism probably. The perfusion flow rate had significant effect on the K(a) and P(app).
Analgesics
;
administration & dosage
;
pharmacokinetics
;
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
administration & dosage
;
pharmacokinetics
;
Colon
;
metabolism
;
Dose-Response Relationship, Drug
;
Duodenum
;
metabolism
;
Female
;
Flurbiprofen
;
administration & dosage
;
pharmacokinetics
;
Ileum
;
metabolism
;
Intestinal Absorption
;
Jejunum
;
metabolism
;
Male
;
Perfusion
;
Rats
;
Rats, Sprague-Dawley
7.Preparation of valsartan nanosuspensions and its in vitro dissolution.
Fei LI ; Shuang-Shuang SONG ; Yun LIU ; Ying-Xin GUO ; Wei-San PAN ; Xing-Gang YANG
Acta Pharmaceutica Sinica 2013;48(8):1312-1318
To increase the dissolution rate and extent of valsartan, valsartan nanosuspensions have been prepared. Controlled precipitation assisted with sonication is utilized to prepare valsartan nanosuspensions, the concentration of the drug, stabilizer and costablizer had a great effect on the stability of the preparation according to the pre-experiment. So the method of central composite design-response surface is used to optimize the prescription based on the above three factors and the particle size as the response value. The software Origin 8.0 is used to draw the view of the three-dimensional effects and 2D contour map, to get the optimal prescription area. Valsartan nanosuspensions were prepared. The mean diameter and zeta potential are about 216.6 nm and -57.7 mV, respectively. Compared with the microsuspensions and commercial preparation, the dissolution of valsartan nanosuspensions was faster and the bioavailability can be enhanced to some extent.
Angiotensin II Type 1 Receptor Blockers
;
administration & dosage
;
chemistry
;
Biological Availability
;
Chemical Precipitation
;
Drug Stability
;
Nanoparticles
;
administration & dosage
;
chemistry
;
ultrastructure
;
Particle Size
;
Research Design
;
Solubility
;
Suspensions
;
Ultrasonics
;
methods
;
Valsartan
;
administration & dosage
;
chemistry
8.Anti-tumor activity of folate receptor targeting docetaxel-loaded membrane-modified liposomes.
Xiang LI ; Jing ZHANG ; Dong-Kai WANG ; Wei-San PAN
Acta Pharmaceutica Sinica 2013;48(7):1142-1147
The anti-tumor activity of folate receptor targeting docetaxel-loaded membrane-modified liposomes (FA-PDCT-L) was investigated in vitro and in vivo. FA-PDCT-L was prepared by organic solvent injection method. Transmission electron microscope, dynamic light scattering and electrophoretic light scattering were employed to study the physicochemical parameters of FA-PDCT-L. The inhibitory effects of docetaxel injection (DCT-I), non-modified DCT liposomes (DCT-L) and FA-PDCT-L on the growth of MCF-7 and A-549 cells at different incubation times were detected by CCK-8 assay; and the hemolytic test was employed in vitro. Tumor mice were randomized into 4 groups: DCT-I, DCT-L, FA-PDCT-L and control group (normal saline), and given drugs at 10 mg x kg(-1) x d(-1) through tail vein. The tumor volume, mice weight, inhibition rate of tumor and life span were measured at the end of experiments. The IC50 of the FA-PDCT-L for MCF-7 and A549 cell lines were significantly lower than that of DCT-I and DCT-L, without hemolysis reaction observed. Compared with control group, the weights of tumor in DCT-I, DCT-L and FA-PDCT-L were decreased, especially for FA-PDCT-L, with inhibitory rates at 79.03 % (P < 0.05). The life span and median survival time of FA-PDCT-L treated mice were significantly higher than that of DCT-I and DCT-L. In conclusion, FA-PDCT-L shows a good anti-tumor activity, indicating that it is potential carriers for DCT in the treatment of tumor.
Animals
;
Antineoplastic Agents
;
administration & dosage
;
pharmacology
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Cyanoacrylates
;
chemistry
;
Drug Carriers
;
Female
;
Folate Receptors, GPI-Anchored
;
chemistry
;
Humans
;
Inhibitory Concentration 50
;
Liposomes
;
chemistry
;
Lung Neoplasms
;
pathology
;
MCF-7 Cells
;
Mice
;
Neoplasm Transplantation
;
Particle Size
;
Polyethylene Glycols
;
chemistry
;
Rabbits
;
Random Allocation
;
Sarcoma 180
;
pathology
;
Taxoids
;
administration & dosage
;
pharmacology
;
Tumor Burden
;
drug effects
9.Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes.
Xiang LI ; Jing ZHANG ; Dong-Kai WANG ; Wei-San PAN
Acta Pharmaceutica Sinica 2012;47(9):1219-1226
A novel amphiphilic copolymer, folate-poly (PEG-cyanoacrylate-co-cholesteryl cyanoacrylate) (FA-PEG-PCHL) was synthesized as liposomal modifying material with folate receptor targeting and long circulating property. FA-PEG-PCHL-modified docetaxel-loaded liposomes (FA-PDCT-L) were prepared by organic solvent injection method, and the system was optimized using central composite design-response surface methodology. The structure of the FA-PEG-PCHL copolymer was confirmed by FT-IR and 1H NMR. Ultrafiltration technique, transmission electron microscope, dynamic light scattering and electrophoretic light scattering, and fluorescence polarization method were used to study the physicochemical parameters of FA-PDCT-L. FA-PDCT-L showed spherical or ellipsoid shape. The mean particle sizes were in the range of 111.6-126.9 nm, zeta potentials were from -6.54 mV to -14.13 mV and the drug encapsulation efficiency achieved 97.8%. The observed values agreed well with model predicted values. The membrane fluidity increased with the increment of the molecular weight of PEG and the decrement of the amount of FA-PEG-PCHL. The in vitro release test showed that the drug could be sustained-released from liposomes without a burst release and with stability for 6 months. After 24 h only 31.1%, 27.2% and 19.5% of encapsulated docetaxel were released for FA-PDCT10000-L, FA-PDCT4000-L and FA-PDCT2000-L, respectively. This work is useful for further research on the application of the synthesized copolymer-modified long circulating liposomes for cancer therapy.
Antineoplastic Agents
;
administration & dosage
;
Cholesterol Esters
;
chemistry
;
Cyanoacrylates
;
chemistry
;
Delayed-Action Preparations
;
Drug Carriers
;
chemical synthesis
;
chemistry
;
Drug Delivery Systems
;
Folate Receptors, GPI-Anchored
;
chemistry
;
Liposomes
;
administration & dosage
;
chemistry
;
Molecular Weight
;
Particle Size
;
Polyethylene Glycols
;
chemistry
;
Polymers
;
chemical synthesis
;
chemistry
;
Taxoids
;
administration & dosage
10.Design push-pull osmotic pump tablets of famotidine based on an expert system for the formulation design of osmotic pump of poor water-soluble drug.
Zhi-Hong ZHANG ; Jie JIN ; Hong-Wu ZHANG ; Wei XIN ; Guo-Bin JIA ; Wen-Fang WU ; Wei-San PAN
Acta Pharmaceutica Sinica 2011;46(1):109-114
The purpose of this study is to design push-pull osmotic pump (PPOP) tablets of famotidine using the expert system for the formulation design of osmotic pump of poor water-soluble drug which had been established by the authors. Firstly, the parameters which were requisite of the system input were obtained from literatures and experimental tests. Then the parameters were input into the system, and the program was run. The system displayed the designed formulations sequential. Finally, famotidine PPOP was prepared according to the designed formulations and the in vitro dissolution was carried out. It was found out that the target formulation of famotidine PPOP which could release for 24 hours was obtained in a very short period. Meanwhile, the practicability of the established expert system was proved.
Delayed-Action Preparations
;
Drug Delivery Systems
;
methods
;
Excipients
;
chemistry
;
Expert Systems
;
Famotidine
;
administration & dosage
;
chemistry
;
Osmosis
;
Solubility
;
Tablets
;
Water

Result Analysis
Print
Save
E-mail